The Medical Foundation Division News
Talking with FDA Commissioner at HRA Meeting
Margaret Hamburg, MD, FDA Commissioner and Sally McNagny, MD, MPH, The Medical Foundation division.
September 28, 2009
Sally McNagny, MD, MPH of The Medical Foundation, a division of HRiA, co-chaired the planning committee for the Health Research Alliance (HRA) meeting at the Howard Hughes Medical Institute in Washington, D.C. The Health Research Alliance (HRA) is a membership organization of nonprofit, non-governmental funders of medical research and training. Collectively, HRA members provide nearly $1.5 billion in research and training awards each year to more than 5,000 investigators in the United States and abroad.
The September meeting featured Margaret Hamburg, M.D., FDA Commissioner, Francis Collins, Ph.D., Director of the National Institutes of Health (NIH) and Albert Teich, PhD, Director of the Science and Policy Programs at the American Association for the Advancement of Science (AAAS). Topics included accelerating drug discovery and development, future directions of the NIH, update on the American Recovery and Reinvestment Act, and an overview of comparative effectiveness research.
The September meeting featured Margaret Hamburg, M.D., FDA Commissioner, Francis Collins, Ph.D., Director of the National Institutes of Health (NIH) and Albert Teich, PhD, Director of the Science and Policy Programs at the American Association for the Advancement of Science (AAAS). Topics included accelerating drug discovery and development, future directions of the NIH, update on the American Recovery and Reinvestment Act, and an overview of comparative effectiveness research.
« Return
Sally McNagny, MD, MPH, FACP
